Diana Ernst, RPh

Most Recent Articles by Diana Ernst, RPh

Empagliflozin Treatment Positively Impacts Life Expectancy in T2D With CVD

Empagliflozin Treatment Positively Impacts Life Expectancy in T2D With CVD

By

For this analysis, the authors used follow-up data from all 7020 patients included in the EMPA-REG OUTCOME trial to estimate the effect of empagliflozin on all-cause mortality vs placebo over the duration of a patient's lifetime.

Lorcaserin Reduces Risk for Incident Diabetes in Patients With Prediabetes

Lorcaserin Reduces Risk for Incident Diabetes in Patients With Prediabetes

By

In this new analysis, researchers looked at the long-term effects of the drug on diabetes prevention and remission in these patients.

New Testosterone Replacement Therapy Approved for At-Home Self-Administration

New Testosterone Replacement Therapy Approved for At-Home Self-Administration

By

Xyosted carries a Boxed Warning regarding blood pressure increases that may potentially increase the risk for major adverse cardiovascular events.

Guidelines for Managing Perimenopausal Depression Now Available

Guidelines for Managing Perimenopausal Depression Now Available

By

The 5 topics addressed by the 11-member expert panel include epidemiology, clinical presentation, therapeutic effects of antidepressants, effects of hormone therapy, and the effectiveness of other therapies (eg, psychotherapy, exercise, natural health products).

Does Adolescent Vaccination Increase Primary Ovarian Insufficiency Risk?

Does Adolescent Vaccination Increase Primary Ovarian Insufficiency Risk?

By

For this study, researchers investigated the incidence of primary ovarian insufficiency incidence and estimated risk for POI after vaccination with human papillomavirus, Tdap, influenza and meningococcal conjugate using Kaiser Permanente Northwest electronic health records from 2006 to 2014.

More Articles by Diana Ernst, RPh

Sign Up for Free e-Newsletters



CME Focus